These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20088742)

  • 21. Computed tomography of the coronary arteries in diagnosis.
    Leschka S; Feuchtner G; Goetti R; Alkadhi H
    Expert Opin Med Diagn; 2010 Mar; 4(2):171-83. PubMed ID: 23484449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors.
    Urbich C; Dimmeler S
    Kidney Int; 2005 May; 67(5):1672-6. PubMed ID: 15840010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor polymorphisms and coronary artery disease: a systemic review and meta-analysis.
    Chen HL; Liu K
    Int J Cardiol; 2014; 172(1):e220-4. PubMed ID: 24439853
    [No Abstract]   [Full Text] [Related]  

  • 24. Important signals regulating coronary artery angiogenesis.
    Shoeibi S; Mozdziak P; Mohammadi S
    Microvasc Res; 2018 May; 117():1-9. PubMed ID: 29247718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Janus-like role of fibroblast growth factor 2 in arteriosclerotic coronary artery disease: atherogenesis and angiogenesis.
    Liu MH; Tang ZH; Li GH; Qu SL; Zhang Y; Ren Z; Liu LS; Jiang ZS
    Atherosclerosis; 2013 Jul; 229(1):10-7. PubMed ID: 23578358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modern outlook on the clinical consequences of angiogenesis].
    Kluz J; Adamiec R
    Pol Arch Med Wewn; 2005 Mar; 113(3):287-95. PubMed ID: 16128288
    [No Abstract]   [Full Text] [Related]  

  • 27. FGF-4 gene therapy GENERX--Collateral Therapeutics.
    BioDrugs; 2002; 16(1):75-6. PubMed ID: 11909005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting angiogenic genes as a therapeutic approach for hepatocellular carcinoma.
    Wong CH; Wong CS; Chan SL
    Curr Gene Ther; 2015; 15(2):97-108. PubMed ID: 25537771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of vascular endothelial growth factor gene as the genetic marker of atherothrombotic disorders and in the gene therapy of coronary artery disease.
    Petrovic D
    Cardiovasc Hematol Agents Med Chem; 2010 Jan; 8(1):47-54. PubMed ID: 20210775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Angiogenesis in Coronary Artery Disease: A Double-Edged Sword: Intraplaque Angiogenesis in Physiopathology and Therapeutic Angiogenesis for Treatment.
    Wu W; Li X; Zuo G; Pu J; Wu X; Chen S
    Curr Pharm Des; 2018; 24(4):451-464. PubMed ID: 29283055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic angiogenesis for ischemic cardiovascular disease.
    Freedman SB; Isner JM
    J Mol Cell Cardiol; 2001 Mar; 33(3):379-93. PubMed ID: 11181008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative therapeutic strategies for patients with severe end-stage coronary artery disease not amenable to conventional revascularization.
    Almeda FQ; Parrillo JE; Klein LW
    Catheter Cardiovasc Interv; 2003 Sep; 60(1):57-66. PubMed ID: 12929105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis.
    Shi L; Zhao M; Abbey CA; Tsai SH; Xie W; Pham D; Chapman S; Bayless KJ; Hein TW; Rosa RH; Ko ML; Kuo L; Ko GY
    J Am Heart Assoc; 2019 Nov; 8(22):e013673. PubMed ID: 31698979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the microRNA, miR-206, and its target PIK3C2α in endothelial progenitor cell function – potential link with coronary artery disease.
    Tang Y; Zhang Y; Chen Y; Xiang Y; Xie Y
    FEBS J; 2015 Oct; 282(19):3758-72. PubMed ID: 26175229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vascular endothelial growth factor therapy in ischaemic heart disease].
    Qayyum AA; Joshi FR; Lund LD; Søndergaard RH; Kastrup J
    Ugeskr Laeger; 2020 Oct; 182(44):. PubMed ID: 33118488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic myocardial angiogenesis with vascular endothelial growth factors.
    Yoon YS; Johnson IA; Park JS; Diaz L; Losordo DW
    Mol Cell Biochem; 2004 Sep; 264(1-2):63-74. PubMed ID: 15544036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF gene therapy cooperatively recruits molecules from the immune system and stimulates cell homing and angiogenesis in refractory angina.
    Eibel B; Markoski MM; Rodrigues CG; Dipp T; de Salles FB; Giusti II; Nardi NB; Plentz RD; Kalil RA
    Cytokine; 2017 Mar; 91():44-50. PubMed ID: 27997860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis.
    Hughes GC; Post MJ; Simons M; Annex BH
    J Appl Physiol (1985); 2003 May; 94(5):1689-701. PubMed ID: 12679343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular growth factors and angiogenesis in cardiac surgery.
    Sellke FW; Ruel M
    Ann Thorac Surg; 2003 Feb; 75(2):S685-90. PubMed ID: 12607713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atorvastatin improves the proliferation and migration of endothelial progenitor cells via the miR-221/VEGFA axis.
    Sun L; Zhang Y; Zhang J; Wang J; Xing S
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 32936287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.